BioLASCO Taiwan Statistics

Total Valuation

BioLASCO Taiwan has a market cap or net worth of TWD 845.20 million. The enterprise value is 789.69 million.

Market Cap	845.20M
Enterprise Value	789.69M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Jul 26, 2024

Share Statistics

BioLASCO Taiwan has 25.61 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class	n/a
Shares Outstanding	25.61M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	19.74%
Owned by Institutions (%)	n/a
Float	18.99M

Valuation Ratios

The trailing PE ratio is 19.20.

PE Ratio	19.20
Forward PE	n/a
PS Ratio	2.89
PB Ratio	1.88
P/TBV Ratio	1.88
P/FCF Ratio	815.83
P/OCF Ratio	14.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.54, with an EV/FCF ratio of 762.24.

EV / Earnings	17.94
EV / Sales	2.70
EV / EBITDA	11.54
EV / EBIT	13.74
EV / FCF	762.24

Financial Position

The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.24.

Current Ratio	3.66
Quick Ratio	3.04
Debt / Equity	0.24
Debt / EBITDA	1.60
Debt / FCF	103.29
Interest Coverage	31.76

Financial Efficiency

Return on equity (ROE) is 9.67% and return on invested capital (ROIC) is 6.48%.

Return on Equity (ROE)	9.67%
Return on Assets (ROA)	5.88%
Return on Invested Capital (ROIC)	6.48%
Return on Capital Employed (ROCE)	10.24%
Revenue Per Employee	3.21M
Profits Per Employee	483,824
Employee Count	91
Asset Turnover	0.49
Inventory Turnover	4.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.30% in the last 52 weeks. The beta is 0.32, so BioLASCO Taiwan's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-4.30%
50-Day Moving Average	33.62
200-Day Moving Average	35.35
Relative Strength Index (RSI)	49.55
Average Volume (20 Days)	11,031

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioLASCO Taiwan had revenue of TWD 292.50 million and earned 44.03 million in profits. Earnings per share was 1.72.

Revenue	292.50M
Gross Profit	114.76M
Operating Income	55.74M
Pretax Income	54.92M
Net Income	44.03M
EBITDA	64.45M
EBIT	55.74M
Earnings Per Share (EPS)	1.72

Full Income Statement

Balance Sheet

The company has 162.52 million in cash and 107.01 million in debt, giving a net cash position of 55.51 million or 2.17 per share.

Cash & Cash Equivalents	162.52M
Total Debt	107.01M
Net Cash	55.51M
Net Cash Per Share	2.17
Equity (Book Value)	449.38M
Book Value Per Share	17.55
Working Capital	181.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 56.86 million and capital expenditures -55.83 million, giving a free cash flow of 1.04 million.

Operating Cash Flow	56.86M
Capital Expenditures	-55.83M
Free Cash Flow	1.04M
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 39.24%, with operating and profit margins of 19.06% and 15.05%.

Gross Margin	39.24%
Operating Margin	19.06%
Pretax Margin	18.78%
Profit Margin	15.05%
EBITDA Margin	22.04%
EBIT Margin	19.06%
FCF Margin	0.35%

Dividends & Yields

This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 4.95%.

Dividend Per Share	1.65
Dividend Yield	4.95%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	1
Payout Ratio	95.98%
Buyback Yield	0.02%
Shareholder Yield	4.96%
Earnings Yield	5.21%
FCF Yield	0.12%

Dividend Details

Stock Splits

The last stock split was on July 30, 2018. It was a forward split with a ratio of 1.055.

Last Split Date	Jul 30, 2018
Split Type	Forward
Split Ratio	1.055

Scores

BioLASCO Taiwan has an Altman Z-Score of 4.82.

Altman Z-Score	4.82
Piotroski F-Score	n/a